Previous Close | 5.81 |
Open | 5.83 |
Bid | 4.50 x 200 |
Ask | 7.38 x 200 |
Day's Range | 5.72 - 6.29 |
52 Week Range | 1.58 - 19.95 |
Volume | |
Avg. Volume | 1,298,785 |
Market Cap | 423.473M |
Beta (5Y Monthly) | -0.70 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.46 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.33 |
CAMBRIDGE, Mass., November 04, 2024--Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
On October 18, 2024, Perceptive Advisors LLC marked a significant portfolio addition by acquiring 8,194 shares of Amylyx Pharmaceuticals Inc (NASDAQ:AMLX). This move not only diversifies Perceptive Advisors LLC's holdings but also strengthens its position in the biotechnology sector. Perceptive Advisors LLC, based at 51 Astor Place, New York, is renowned for its sharp focus on the Healthcare and Financial Services sectors.